Back

Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?

European Heart Journal

28 October 2022
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes

Contributors

Cheng Xie
Cheng Xie

Author

Yuzhen Zhang
Yuzhen Zhang

Author

Jia Lin
Jia Lin

Author

You may be interested in
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Congress Presentation
Peripheral atherosclerosis and abdominal aortic aneurysm as a new risk factors of upper gastrointestinal bleeding in patients with stable CAD receiving long-term antithrombotic therapy.
15 April 2021
thumbnail
Congress Presentation
Patients with acute coronary syndrome.
18 March 2022
thumbnail
Congress Presentation
Comparison of the new BLLADS score with other scores for the prediction of major bleeding in patients with acute pulmonary embolism
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources